Estrogens, progestins, and coronary artery reactivity in atherosclerotic monkeys.
It has been known for many years that sex hormones modulate vasodilator responses of arteries supplying the uterus with blood. Recently, it has been shown that sex hormones such as estrogen modulate vasomotor responses of other arteries, including coronary arteries. It is thought that modulation of vasodilator and constrictor responses of coronary arteries may be one mechanism by which estrogen affects the risk of coronary heart disease. Although several studies have examined the effects (and potential mechanisms) of estrogen on vasodilator responses of nonatherosclerotic arteries, few have focused on estrogen's effects on atherosclerotic coronary arteries. In studies of ovariectomized atherosclerotic female cynomolgus monkeys, both long-term (2 years) and short-term (20 min) estradiol treatment augments dilator responses to acetylcholine, but not nitroglycerin. Presumably, this indicates an effect of estradiol on endothelium-mediated dilator responses of coronary arteries. Addition of the progestin medroxyprogesterone acetate diminishes the beneficial effect of conjugated equine estrogens on these dilator responses. This is significant because a progestin is usually added to estrogen replacement to reduce the risk of endometrial and breast cancer associated with unopposed estrogen therapy. However, it would seem that not all progestins act similarly on vascular reactivity. Studies in monkeys indicate that addition of progesterone or the progestin medroxyprogesterone acetate does not diminish the beneficial effects of estrogen on coronary dilator responses. Thus it would appear that different estrogen/progestin combinations may affect vascular reactivity in different manners, There is also an effort being made to examine the potential of different kinds of estrogens on cardiovascular risk. Studies in monkeys indicate that one of the estrogens found in conjugated equine estrogens (17 alpha-dihydroequilenin) has estrogen effects on vascular reactivity without having detrimental effects on uterine pathology. The isoflavones "plant estrogens" found in soy protein also have estrogenic effects on vascular reactivity and inhibition.
Williams
J K
JK
The Comparative Medicine Clinical Research Center, Department of Comparative Medicine, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC, USA. kwilliams@cpm.bgsm.edu
Delansorne
R
R
Paris
J
J
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D003324:Coronary Artery Disease / Q000503:physiopathology* / Q000517:prevention & control; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D008252:Macaca fascicularis; D008297:Male; D017258:Medroxyprogesterone Acetate / Q000494:pharmacology; D008535:Megestrol; D009649:Norpregnadienes / Q000494:pharmacology; D017697:Premenopause; D011372:Progestins / Q000494:pharmacology*; D012727:Sex Characteristics; D014664:Vasodilation / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology
D004967:Estrogens; D009649:Norpregnadienes; D011372:Progestins; D014665:Vasodilator Agents; C038501:nomegestrol acetate; D017258:Medroxyprogesterone Acetate; D008535:Megestrol; D000109:Acetylcholine